• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Scientific Publications by FDA Staff

  • Print
  • Share
  • E-mail
-

Search Publications



Fields



Centers











Starting Date


Ending Date


Order by

Entry Details

Acad Radiol 2014 Apr;21(4):481-90

Comparative Statistical Properties of Expected Utility and Area Under the ROC Curve for Laboratory Studies of Observer Performance in Screening Mammography.

Abbey CK, Gallas BD, Boone JM, Niklason LT, Hadjiiski LM, Sahiner B, Samuelson FW

Abstract

RATIONALE AND OBJECTIVES: Our objective is to determine whether expected utility (EU) and the area under the receiver operator characteristic (AUC) are consistent with one another as endpoints of observer performance studies in mammography. These two measures characterize receiver operator characteristic performance somewhat differently. We compare these two study endpoints at the level of individual reader effects, statistical inference, and components of variance across readers and cases. MATERIALS AND METHODS: We reanalyze three previously published laboratory observer performance studies that investigate various x-ray breast imaging modalities using EU and AUC. The EU measure is based on recent estimates of relative utility for screening mammography. RESULTS: The AUC and EU measures are correlated across readers for individual modalities (r = 0.93) and differences in modalities (r = 0.94 to 0.98). Statistical inference for modality effects based on multi-reader multi-case analysis is very similar, with significant results (P < .05) in exactly the same conditions. Power analyses show mixed results across studies, with a small increase in power on average for EU that corresponds to approximately a 7% reduction in the number of readers. Despite a large number of crossing receiver operator characteristic curves (59% of readers), modality effects only rarely have opposite signs for EU and AUC (6%). CONCLUSIONS: We do not find any evidence of systematic differences between EU and AUC in screening mammography observer studies. Thus, when utility approaches are viable (i.e., an appropriate value of relative utility exists), practical effects such as statistical efficiency may be used to choose study endpoints.


Category: Journal Article
PubMed ID: #24594418 DOI: 10.1016/j.acra.2013.12.011
Includes FDA Authors from Scientific Area(s): Medical Devices
Entry Created: 2014-03-07 Entry Last Modified: 2014-05-10
Feedback
-
-